Paid Plans
Want to analyze multiple companies at once? Paid plans let you compare up to 5 stocks side by side.
Sign Up
G
389030
vs
K
KOSPI 200
Over the past 12 months, Geninus Inc has underperformed KOSPI 200, delivering a return of -36% compared to KOSPI 200's +42% growth.
Stocks Performance
389030 vs KOSPI 200
Performance Gap
389030 vs KOSPI 200
Create a free account · No card needed
Performance By Year
389030 vs KOSPI 200
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Geninus Inc
Glance View
Geninus Inc is a South Korean biotechnology company that focuses on genetic testing and genomic analysis. It develops and sells testing services and related software that help doctors and researchers read DNA data and use it to guide medical decisions, especially in areas like cancer and other disease diagnostics. The company makes money by selling laboratory testing services, genetic analysis products, and data interpretation tools to hospitals, medical institutions, research groups, and other healthcare customers. In practice, Geninus sits between raw DNA data and usable medical insight: it processes samples, analyzes genetic changes, and turns that information into reports that support diagnosis and treatment planning. What makes its business different is that it is not a drug maker or a traditional medical-device seller. Its value comes from expertise in genomics, lab workflows, and bioinformatics, which lets it act as a specialized service provider in the precision medicine chain.
Create a free account · No card needed